Dr. Riabowol awarded prestigious Killam Annual Professorship

 

Dr. Karl Riabowol is a recipient of the prestigious Killam Annual Professorship, one of four awarded for 2014.  

The Killam Annual Professorship associates the prestige of a Killam award with the university’s recognition of excellence across diverse domains of academic activity.  Winners of the Killam Annual Professor award will have demonstrated excellence in the following primary areas: research, undergraduate and/or graduate teaching. Service to their academic discipline, and/or service to the community beyond the University, will be considered as supportive of the primary excellence criteria, however service on its own will not be sufficient to merit the award.

Dr. Riabowol, a professor in the departments of Biochemistry & Molecular Biology and Oncology, joined the University of Calgary as an AHFMR Scholar and started a research program that is renowned for discovering a new family of tumor suppressors. Riabowol’s program is also the world leader in defining how these suppressors operate for cancer diagnosis and treatment. Riabowol is a full member of the Southern Alberta Cancer Research Institute, the Children’s Hospital Research Institute and is the founder and director of the University of Calgary’s core antibody facility.